A Retrospective, Single-Center Study Comparing Neoadjuvant ACTHP vs. DCbHP in HER2-Positive Early Breast Cancer Patients.

Authors: Itay, Amit¹ (AUTHOR) amit.itay@sheba.gov.il, Globus, Opher¹ (AUTHOR) keren.levanon@sheba.gov.il, Levanon, Keren^1,2 (AUTHOR) tal.sella@sheba.gov.il, Sella, Tal¹ (AUTHOR) rinat.bernstein@sheba.gov.il, Bernstein-Molho, Rinat¹ (AUTHOR) tal.shapirarotenberg@sheba.gov.il, Shapira, Tal¹ (AUTHOR) cecilie.oedegaard@sheba.gov.il, Oedegaard, Cecilie¹ (AUTHOR) dana.fourey@sheba.gov.il, Fourey, Dana¹ (AUTHOR), Nili Gal Yam, Einav^1,2 (AUTHOR) amit.itay@sheba.gov.il

Source: Cancers. Jan2025, Vol. 17 Issue 2, p250. 10p.

Subject Terms: *THERAPEUTIC use of antineoplastic agents, *HORMONE receptor positive breast cancer, *PATHOLOGIC complete response, *RETROSPECTIVE studies, *COMBINED modality therapy, *ANTHRACYCLINES, *DRUG efficacy, *CARDIOTOXICITY, *MEDICAL records, *ACQUISITION of data, *COMPARATIVE studies

Geographic Terms: ISRAEL

The Role of 68Ga-FAPI PET/CT in Breast Cancer Response Assessment and Follow-Up

Authors: Eshet, Yael, Tau, Noam, Levanon, Keren, Bernstein-Molho, Rinat, Globus, Ofer, Itay, Amit, Shapira, Tal, Oedegaard, Cecilie, Eifer, Michal, Davidson, Tima, Nidam, Meital, Gal-Yam, Einav, Domachevsky, Liran

Source: Clinical nuclear medicine. 48(8):685-688

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100191709781.0x000001&indx=1&recIds=ETOCvdc_100191709781.0x000001

The Role of 68Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer

Authors: Eshet, Yael, Tau, Noam, Apter, Sara, Nissan, Noam, Levanon, Keren, Bernstein-Molho, Rinat, Globus, Ofer, Itay, Amit, Shapira, Tal, Oedegaard, Cecilie, Gorfine, Malka, Eifer, Michal, Davidson, Tima, Gal-Yam, Einav, Domachevsky, Liran

Source: Clinical nuclear medicine. 48(3):228-232

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186828267.0x000001&indx=1&recIds=ETOCvdc_100186828267.0x000001

Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours

Authors: Margalit, Ofer, Shacham-Shmueli, Einat, Itay, Amit, Berger, Raanan, Halperin, Sharon, Jurkowicz, Menucha, Levin, Einav G., Olmer, Liraz, Regev-Yochay, Gili, Lustig, Yaniv, Rahav, Galia

Source: European journal of cancer. 168:51-55

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100195063853.0x000001&indx=1&recIds=ETOCvdc_100195063853.0x000001

Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study

Authors: Shmueli, Einat S., Itay, Amit, Margalit, Ofer, Berger, Raanan, Halperin, Sharon, Jurkowicz, Menucha, Levin, Einav G., Levy, Itzchak, Olmer, Liraz, Regev-Yochay, Gili, Lustig, Yaniv, Rahav, Galia

Source: In European Journal of Cancer November 2021 157:124-131

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy

Authors: Stemmer, Salomon, Steiner, Mariana, Rizel, Shulamith, Ben-Baruch, Noa, Uziely, Beatrice, Jakubowski, Debbie, Baron, Julie, Shak, Steven, Soussan-Gutman, Lior, Bareket-Samish, Avital, Fried, Georgeta, Rosengarten, Ora, Itay, Amit, Nisenbaum, Bella, Katz, Daniela, Leviov, Michelle, Tokar, Margarita, Liebermann, Nicky, Geffen, David

Source: NPJ breast cancer. 5:1-6

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100191099424.0x000001&indx=1&recIds=ETOCvdc_100191099424.0x000001

Serological response to a third booster dose of BNT162b2 COVID‐19 vaccine among seronegative cancer patients

Authors: Shmueli, Einat Shacham, Lawrence, Yaacov R., Rahav, Galia, Itay, Amit, Lustig, Yaniv, Halpern, Naama, Boursi, Ben, Margalit, Ofer

Source: Cancer reports. 5(8)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100157760327.0x000001&indx=1&recIds=ETOCvdc_100157760327.0x000001

Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study

Authors: Shacham-Shmueli, Einat, Itay, Amit, Margalit, Ofer, Berger, Raanan, Halperin, Sharon, Jurkowicz, Menucha, Levin, Einav G., Levy, Itzchak, Olmer, Liraz, Regev-Yochay, Gili, Lustig, Yaniv, Rahav, Galia

Source: European journal of cancer. 160:285-286

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100151123923.0x000001&indx=1&recIds=ETOCvdc_100151123923.0x000001

ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

Authors: Zundelevich, Adi, Dadiani, Maya, Kahana-Edwin, Smadar, Itay, Amit, Sella, Tal, Gadot, Moran, Cesarkas, Karen, Farage-Barhom, Sarit, Saar, Efrat Glick, Eyal, Eran, Kol, Nitzan, Pavlovski, Anya, Balint-Lahat, Nora, Dick-Necula, Daniela, Barshack, Iris, Kaufman, Bella, Gal-Yam, Einav Nili

Source: Breast cancer research. 22(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100164301971.0x000001&indx=1&recIds=ETOCvdc_100164301971.0x000001

Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

Authors: Zundelevich, Adi, Dadiani, Maya, Kahana-Edwin, Smadar, Itay, Amit, Sella, Tal, Gadot, Moran, Cesarkas, Karen, Farage-Barhom, Sarit, Saar, Efrat Glick, Eyal, Eran, Kol, Nitzan, Pavlovski, Anya, Balint-Lahat, Nora, Dick-Necula, Daniela, Barshack, Iris, Kaufman, Bella, Gal-Yam, Einav Nili

Source: Breast cancer research. 22(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100164288316.0x000001&indx=1&recIds=ETOCvdc_100164288316.0x000001

The Role of 68 Ga-FAPI PET/CT in Breast Cancer Response Assessment and Follow-Up.

Authors: Eshet, Yael, Tau, Noam, Levanon, Keren, Bernstein-Molho, Rinat, Globus, Ofer, Itay, Amit, Shapira, Tal, Oedegaard, Cecilie, Eifer, Michal, Davidson, Tima, Nidam, Meital, Gal-Yam, Einav, Domachevsky, Liran

Source: Clinical Nuclear Medicine; Aug2023, Vol. 48 Issue 8, p685-688, 4p

Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study.

Authors: Rotem, Ofer, Peretz, Idit, Leviov, Michelle, Kuchuk, Iryna, Itay, Amit, Tokar, Margarita, Paluch-Shimon, Shani, Maimon, Ofra, Yerushalmi, Rinat, Drumea, Karen, Evron, Ella, Sonnenblick, Amir, Gal-Yam, Einav, Goldvaser, Hadar, Samih, Yosef, Merose, Rotem, Bareket-Samish, Avital, Soussan-Gutman, Lior, Stemmer, Salomon M.

Source: NPJ Breast Cancer; 6/2/2023, Vol. 9 Issue 1, p1-8, 8p

The Role of 68 Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer.

Authors: Eshet, Yael, Tau, Noam, Apter, Sara, Nissan, Noam, Levanon, Keren, Bernstein-Molho, Rinat, Globus, Ofer, Itay, Amit, Shapira, Tal, Oedegaard, Cecilie, Gorfine, Malka, Eifer, Michal, Davidson, Tima, Gal-Yam, Einav, Domachevsky, Liran

Source: Clinical Nuclear Medicine; Mar2023, Vol. 48 Issue 3, p228-232, 5p

This result is not displayed to guests.
Login for full access.